Списък на цитиранията на публикации на




ИмеСписък на цитиранията на публикации на
Дата на преобразуване21.10.2012
Размер82 Kb.
ТипДокументация
източникhttp://www.bscth.med-bg.info/site/documents/rykovodstvo/List_citations_Genova_2010.doc
СПИСЪК

на цитиранията на публикации на

на ст.н.с. ІІ ст. д-р Маргарита Любенова Генова, дм



L Mitev, S Christova, E Hadjiev, M Guenova, R Oucheva, I Valkov, and Y Manolova. A new variant chromosomal translocation t(2;2)(p23;q23) in CD30+/Ki-1+ anaplastic large cell lymphoma. Leuk Lymphoma, February 1, 1998; 28(5-6): 613-6.]

  1. Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol. 37(4):396-411, 2000

  2. Cordell Jacqueline L., Karen A.F. Pulford, Barbara Bigerna, Giovanna Roncador, Alison Banham, Emanuela Colombo, Pier-Giuseppe Pelicci, David Y. Mason, and Brunangelo Falini. Detection of Normal and Chimeric Nucleophosmin in Human Cells. Blood, January 15, 1999; 93(2):: 632 - 642.

  3. Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia.;14(9):1533-59, 2000

  4. Duyster J, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene. 20(40):5623-37, 2001

  5. Herbst Hermann  and Hans G. Drexler, CD30-Positive Anaplastic Large Cell Lymphoma Cell Lines. (Chapter 12) In: Palsson, Bernhard, and John R. W. Masters (eds.), Human Cell Culture. Volume III, Cancer Cell Lines Part 3: Leukemias and Lymphomas. Kluwer Academic Publishers, Springer Netherlands, ISBN 978-0-7923-6225-8, 2002, pages: 355-370

  6. Hernandez L, Pinyol M, Hernandez S, Bea S, Pulford K, Rosenwald A, Lamant L, Falini B, Ott G, Mason DY, Delsol G, Campo E. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood, 94(9):3265-8, 1999

  7. Ishii E, Honda K, Nakagawa A, Urago K, Oshima K. Primary CD30/Ki-1 positive anaplastic large cell lymphoma of skeletal muscle with der(17)t(1;17)(q11;p11). Cancer Genet Cytogenet, ,122(2):116-20, 2000

  8. Morris SW, Xue L, Ma Z, Kinney MC. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma. Br J Haematol;113(2):275-95, 2001

  9. Paulli M, Vallisa D, Viglio A, Boveri E, Kindl S, Vassallo G, Magrini U, Cavanna L. ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult. Haematologica. 86(3):260-5, 2001

  10. Piccaluga PP, Ascani S, Fraternali Orcioni G, Piccioli M, Pileri Jr A, Falini B, Pileri S. Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. Haematologica.;85(9):978-81, 2000

  11. Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M, Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B. The pathologist's view point. Part II --aggressive lymphomas. Haematologica, 85(12):1308-21, 2000

  12. Pulford Karen, Brunangelo Falini, Jaqueline Cordell, Andreas Rosenwald, German Ott, Hans-Konrad Müller-Hermelink, Kenneth A. MacLennan, Laurence Lamant, Antonio Carbone, Elias Campo, and David Y. Mason. Biochemical Detection of Novel Anaplastic Lymphoma Kinase Proteins in Tissue Sections of Anaplastic Large Cell Lymphoma. Am. J. Pathol., June 1, 1999; 154: 1657 – 1663

  13. Sherman C.G., M. Zielenska, A.N. Lorenzana, et al. Morphological and Phenotypic Features in Pediatric Large Cell Lymphoma and Their Correlation with ALK Expression and the t(2;5)(p23;q35) Translocation. Pediatric and Developmental Pathology , 4(2): 129-137, 2001

  14. Suzuki R, Kagami Y, Takeuchi K, Kami M, Okamoto M, Ichinohasama R, Mori N, Kojima M, Yoshino T, Yamabe H, Shiota M, Mori S, Ogura M, Hamajima N, Seto M, Suchi T, Morishima Y, Nakamura S. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood.;96(9):2993-3000, 2000

  15. Sverre H & F.Mittelman (eds), Chromosomal and Molecular Genetic Aberrations of Tumor Cells, Wiley-Blackwell, New Jersey, 2009, page 363

  16. Tort Frederic, Magda Pinyol, Karen Pulford, Giovanna Roncador, Lluis Hernandez, Iracema Nayach, Hanneke C. Kluin-Nelemans, Philip Kluin, Christian Touriol, Georges Delsol, David Mason and Elías Campo, Molecular Characterization of a New ALK Translocation Involving Moesin (MSN-ALK) in Anaplastic Large Cell Lymphoma. Laboratory Investigation, 81 (issue 3): 419-426, 2001

  17. Turturro Francesco, Prem Seth, and Charles J. Link, Jr. In Vitro Adenoviral Vector p53-mediated Transduction and Killing Correlates with Expression of Coxsackie-Adenovirus Receptor and ß5 Integrin in SUDHL-1 Cells Derived from Anaplastic Large-Cell Lymphoma. Clin. Cancer Res., January 1, 2000; 6(1): 185 - 192.

  18. Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol. 2004 Jun;199(3):330-58.

  19. Fan YS, Rizkalla K. Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis. a summary of 154 cases. Cancer Genet Cytogenet. 2003 May;143(1):73-9.







Guenova, M., Rassidakis, G., Gourgoulis, V., Angeloupoulou,M., et al., p16INK4A is regularly expressed in Hodgkin’s Disease: Comparison with Retinoblastoma, p53, MDM2 protein status, and the presence of Epstein-Barr Virus. Modern Pathology, 12(11):1062-1071, 1999

  1. Bai, Maria, Elena Tsanou, Niki John Agnantis, Sevasti Kamina, Constantina Grepi, Kalliopi Stefanaki, Dimitra Rontogianni, Vassiliki Galani and Panagiotis Kanavaros, Proliferation profile of classical Hodgkin’s lymphomas. Increased expression of the protein cyclin D2 in Hodgkin’s and Reed–Sternberg cells. Modern Patholog , 17(11), 1338-45, 2004

  2. Bai, Maria, Papoudou-Bai, A., Kitsoulis, P., Horianopoulous, N., Kamina, S., Agnatis, NJ, Kanavaros, P., Cell Cycle and Apoptosis Deregulation in Classical Hodgkin Lymphomas. In vivo, 19(2): 439-453:, 2005

  3. Chui Daniel T.Y., David Hammond, Margaret Baird, Lesley Shield, Robert Jackson, Ruth F. Jarrett.Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes, Chromosomes and Cancer, Volume 38, Issue 2 , 2003. Pages 126-136, Published Online: 8 Aug 2003.

  4. Collot-Teixeira Sophie, Implication de l'herpèsvirus humain de type 6 (HHV-6) dans la lymphomogenèse du lymphome de Hodgkin : Rôle de l'oncogène viral DR7. THESE Pour obtenir le grade de Docteur De L'universite De Limoges, 12 Nov 2003

  5. Drakos Elias, Athanasios Thomaides, L. Jeffrey Medeiros, Jiang Li, Vasiliki Leventaki, Marina Konopleva, Michael Andreeff and George Z. Rassidakis. Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma. Clinical Cancer Research 13, 3380-3387, June 1, 2007.

  6. Fan, Wang,   Ma Jin-Long  Wang Jia-Yao  Zhao Yue-Ran  Liu Ying, Expression of P16INK4A, CDK4 and cyclin D1 protein in uterine smooth muscle tumors. Acta Universitatis Medicinalis Nanjing, 2007 Vol.27 No.4 P.356-359,封3 [in Chinese]

  7. Giordano, Antonio & Kenneth J. Soprano (eds). Cell cycle inhibitors in cancer therapy: current strategies. Humana Press Inc, New Jersey, 2003, page 248 - ref#324

  8. Jones D, Weissmann DJ, Kraus MD, Hasserjian RP, Shahsafaei A, Dorfman DM. Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease. Am J Clin Pathol;114(3):438-47, 2000

  9. Kanavaros P, K Stefanaki, J Vlachonikolis, G Eliopoulos, S Kakolyris, D Rontogianni, V Gorgoulis, and V Georgoulias, Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's. lymphomas. Histol Histopathol, 15(2): 445-53, Apr 2000

  10. Kim L., S. Peh, S. Poppema. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death?.  Human Pathology, Volume 37, Issue 1, Pages 92-100

  11. O'Neill, Ciaran J MB; McCluggage, W Glenn FRCPath p16 in gynaecological [p16 Expression in the Female Genital Tract and Its Value in Diagnosis. Advances in Anatomic Pathology. 13(1):8-15, January 2006

  12. Scambia, G, Lovergine, S and V Masciullo, RB family members as predictive and prognostic factors in human cancer. Oncogene, 25(38):5302-8. 2006

  13. Vassilakopoulos Theodoros P., Gerassimos A. Pangalis, Biological prognostic factors in Hodgkin's lymphoma. Haema, 7(2):147-164, 2004







Balatzenko G, Guenova M: Light microscopic detection of BCRABL transcripts after in-cell RT-PCR: Fusion gene expression might correlate with clinical evolution of chronic myeloid leukemia. L e u k Lymph 2000;36(3–4):383–396.

  1. Deutsch Eric, Aymeric Dugray, Bassam AbdulKarim, Elisabetta Marangoni, Laurence Maggiorella, Sabine Vaganay, Radia M'Kacher, Setha Douc Rasy, François Eschwege, William Vainchenker, Ali G. Turhan, and Jean Bourhis. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood, April 1, 2001; 97: 2084 - 2090

  2. Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR-ABL and BCL- 2 in myeloid progenitors leads to myeloid leukemias. Proceedings of the National Academy of Sciences of the United States of America, 100(17):10002–10007, 2003

  3. Jun Yong-Hui Wu Jianzhong Zhang Yongning quarter Chaoyang Huarong Tang Fei Xia Chun Yun Wei Wang Faren, Application of real-time quantitative PCR for detection of chronic myeloid leukemia patients in the clinical significance of unlimited transcripts. Shaanxi Medical Journal (SHAANXI MEDICAL JOURNAL), Vol.33(12): 1109-1111, 2004 .

  4. Krskova-Honzatkova L, Cermak J, Sajdova J, Stary J, Sedlacek P, Sieglova Z. Loss of heterozygosity and heterogeneity of its appearance and persisting in the course of acute myeloid leukemia and myelodysplastic syndromes. Leukemia Research. 25(1):45-53, 2001

  5. Mazzella Fermina M., MD Jacqueline P. Burns, PhD Carmelita J. Alvares, MD, Harold R. Schumacher, MD, La diagnostica molecolare dei distrurbi ematologici.( Molecular diagnostics in hematological disorders) Journal of Clinical Ligand Assay 2001;24:177–196.

  6. Verma RS, Chandra P. Clinical significance of reverse BCR/ABL gene rearrangement in Ph-negative chronic myelogenous leukemia. Leukemia Research. 24(7): 631-5, 2000




Balatzenko G, Guenova M, Zechev J, Toshkov S. Acute megakaryoblastic leukaemia with extreme thrombocytosis and p190(bcr/abl)rearrangement. Ann Hematol., 83(6):381-5, 2004

  1. "Mitelman Database of Chromosome Aberrations in Cancer (2007). Mitelman F, Johansson B and Mertens F (Eds.), http://cgap.nci.nih.gov/Chromosomes/Mitelman". 2007

  2. Alacacioglu I, Ozcan MA, Piskin O, Demirkan F, Ozsan GH, Undar B.Chronic myeloid leukaemia associated with extreme thrombocytosis. Haema; 8(4): 701-703, 2005.

  3. Farias, Mariela G. & Maristela B. Biermann2Análise morfológica, imunofenotípica e molecular na identificação da leucemia megacariocítica aguda (LMA-M7). Morphologic, cytogenetic and molecular analyses in the identification of acute megakaryocytic leukemia (AML-M7) Rev. bras. hematol. hemoter. 2007;29(4):387-393

  4. Park Hee-Myung, Alan R. Doster, Roksana E. Tashbaeva, Young-Mee Lee, Young S. Lyoo, Sang-Jin Lee, Hee-Jung Kim, Jung-Hyang Sur, Clinical, histopathological and immunohistochemical findings in a case of megakaryoblastic leukemia in a dog. J Vet Diagn Invest 18:287–291, 2006

  5. Pompettia Franca, Antonio Spadano, Antonella Saub, Antonio Mennuccia, Rosa Russoa, Virginia Catinellac, Paolo Guanciali Franchid, Giuseppe Calabresed, Giandomenico Palkad, Giuseppe Fioritonib and Antonio Iaconea, Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate. Leukemia Research, Volume 31, Issue 4, April 2007, Pages 563-567




Nikolova, M., Guenova, M., Taskov, H., Dimitrova, E. and Staneva, M. (1998) Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. Leukemia Res. 22, 39–47

  1. Aledo JC. Glutamine breakdown in rapidly dividing cells: waste or investment? Bioessays. 2004 Jul;26(7):778-85.

  2. Dutot Ingrid. La molecule SC3, une nouvelle structure definie a la surface des lymphocytes b humains par un anticorps monoclonal : expression cellulaire et proprietes fonctionnelles. Ministere de la jeunesse, de l’education nationale et de la recherche ecole pratique des hautes etudes. Sciences de la Vie et de la Terre. Memoire Présenté par Ingrid Dutot Pour l’obtention du diplôme de l’Ecole Pratique des Hautes Etudes, 2007

  3. Hyde Russell, Reter M. Taylor, Harinder S. Hundal, Amino acid transporters: roles in amino acid sensing and signalling in animal cells( Review Article). Biochem. J. (2003) 373, 1–18

  4. Stockerl-Goldstein Keith E., Karl G. Blume, Allogeneic Hematopoietic Cell Transplantation for Adult Patients With Acute Myeloid Leukemia (Chapter 75). In Karl G. Blume, Stephen J. Forman, Frederick R. Appelbaum (eds.) Thomas' Hematopoietic Cell Transplantation (Third Edition), pp: 1025-1039, Copyright © 2004 by Blackwell Publishing Ltd, DOI: 10.1002/9780470987070.

  5. Tsurudome M, Ito Y Function of fusion regulatory proteins (FRPs) in immune cells and virus-infected c ells. Crit Rev Immunol 2000 Vol. 20 (3): 167-196

  6. Yanagida, O., Y. Kanai, A. Chairoungdua, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines, Biochimica et Biophysica Acta (BBA) - Biomembranes, Vol. 1514, 2001, (2), 291-302 .







Konstantinov, S., Kostovski, A., Topashka, M., Guenova, M., Berger, M., Comparative cytotoxic efficacy of Bendamustine on human leukemia and breast cancer cell lines. Journal of Cancer Research and Clinical Oncology, 128: 271-278, 2002

  1. Apostolopoulos C, Castellano L, Stebbing J, Giamas G. Bendamustine as a model for the activity of alkylating agents. Future Oncol. 2008 Jun;4(3):323-32.

  2. Augustyniak CZ, D Blamble, B PharmD, C Fausel et al., New perspectives in the treatment of hematologic malignancies. Adv Stud Med, 7(4): 105-118, 2007

  3. Blumel S, Goodrich A, Martin C, Dang NH. Bendamustine: a novel cytotoxic agent for hematologic malignancies. Clin J Oncol Nurs. 2008 Oct;12(5):799-806.

  4. Eichbaum MHR, Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase __ study. Anti-Caner Drugs. 2007; 18(8): 963-968

  5. Gaul L, Mandl-Weber S, Baumann P, Emmerich B, Schmidmaier R. Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways. J Cancer Res Clin Oncol. 2008 Feb;134(2):245-53. Epub 2007 Jul 25.

  6. Gerecitano, John  and Owen A. O’Connor, Novel Small Molecules in the Treatment of Lymphomas. In John P. Leonard and Morton Coleman (eds.) Hodgkin’s and Non-Hodgkin’s Lymphoma. Cancer Treatment and Research, 131: 413-460, 2006

  7. Kalaycio, Matt, Bendamustine - A New Look at an Old Drug. Cancer 2009;115:473–9

  8. Kalaycio, Matt, Clinical Experience with Bendamustine: A New Treatment for Patients with Chronic Lymphocytic Leukemia. Clinical Leukemia, Vol. 2, No. 4, 223-229, 2008

  9. Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J, Elliott G, Niemeyer CC. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008 Jan 1;14(1):309-17.

  10. Masiello D, Tulpule A. Bendamustine therapy in chronic lymphocytic leukemia. Expert Opin Pharmacother. 2009 Jul;10(10):1687-98.

  11. Pirvulescu Cristina, Gunter von Minckwitz, Sibylle Loibl, Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design. Breast Care 2008;3:333-339

  12. Rasschaert M, Schrijvers D, Van den Brande J, Dyck J, Bosmans J, Merkle K, Vermorken JB. A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors. Anticancer Drugs. 2007 Jun;18(5):587-95.

  13. Rasschaert M, Schrijvers D, Van den Brande J, Dyck J, Bosmans J, Merkle K, Vermorken JB. A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours. Br J Cancer. 2007 Jun 4;96(11):1692-8.

  14. Staib Peter, Jan Tiehen , Timo Strunk , Timo Schinköthe, Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. BMC Cancer. 2005 Jun 11;5 (1):60 15949045

  15. Teichert J, Sohr R, Hennig L, Baumann F, Schoppmeyer K, Patzak U, Preiss R. Identification and quantitation of the N-acetyl-L-cysteine S-conjugates of bendamustine and its sulfoxides in human bile after administration of bendamustine hydrochloride. Drug Metab Dispos. 2009 Feb;37(2):292-301. Epub 2008 Oct 29.

  16. Teichert Jens, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca, and Rainer Preiss, Synthesis and characterization of some new phase II metabilites of the alkylator Bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma. Drug Metabolism and Disposition Fast Forward . First published on April 21, 2005; DOI: 10.1124/dmd.105.003624




Tsoneva I, Nikolova B, Georgieva M, Guenova M, Tomov T, Rols MP and Berger MR (2005) Induction of apoptosis by electrotransfer of positively charged proteins as cytochrome C and histone H1 into cells. Biochim Biophys Acta 1721, 55-64.

  1. Naved Alam and Donald B. Sittman* Characterization of the cytotoxic effect of a chimeric restriction enzyme, H1∫-FokI Gene Ther Mol Biol Vol 10, 147-160, 2006

  2. Duce JA , Smith DP ,DP Smith, Blake RE, Crouch PJ, Masters CL Trounce IA Linker histone H1 binds to disease associated amyloid-like fibrils. Journal of Molecular Biology , 2006, 361 : P.493-505

  3. Kutsyi M. P. Histones Induce the Release of Apoptogenic Factors from Liver Mitochondria. Biology Bulletin (ISSN 1062-359), 2009, Vol. 36, No. 4, pp. 328–332

  4. Kutsyi M. P. Gistony vyzyvayut vykhod apoptogennykh belkovykh faktorov iz mitokhondrii pecheni. Izvestiya RAN. Seriya biologicheskaya . № 4, 2009, S. 395-400 (М. П. Куцый, Гистоны вызывают выход апоптогенных белковых факторов из митохондрий печени. Известия РАН. Серия биологическая. №4, Июль-Август 2009, С. (395-400)

  5. Yuan Ai Yun, Jiang Li, Li Xin, Influences of age and duration of status convulsivus on cytochrome C release in hippocampus. 2007【关键词】  惊厥, Ref#2

  6. Vani G., A.J. Vanisree and C.S. Shyamaladevi Histone H1 inhibits the proliferation of MCF 7 and MDA MB 231 human breast cancer cells, Cell Biology International
    Volume 30, Issue 4, April 2006, Pages 326-331




Guenova,M., Taskov, H., Zechev, J., CD4+ Acute undifferentiated leukaemia, probably early monoblastic type, developing in a patient with myelodysplastic syndrome and bone marrow fibrosis. Leukemia and Lymphoma, 26(3-4): 399-404, 1997

  1. Zojer N, Meran JG, Vesely M, Gruner H, Ackermann J, Dellinger C, Zimmer-Roth I, Heinz R, Drach J, Ludwig H. Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia. Leuk Lymphoma, 35(3-4): 415-421, 1999




Balatzenko G., Guenova M., Stoimenov A., Jotov G., Toshkov S. Philadelphia Chromosome Positive Chronic Myeloid Leukemia with p190BCR ABL Rearrangement, Overexpression of EVI1 gene and Extreme Thrombocytosis – a Case Report. Cancer Genetics and Cytogenetics, 2008

  1. Farhi D.C. Bone Marrow and Blood Cells, Lippincott Williams & Wilkins, a Wolters Kluwer business, Baltimore, 2009, cited on page 246, ref#141- page 385







Shivarov V, Dimitrov J, Guenova M, Lymphoid neoplasms in Bulgaria according to the WHO classification (2001). The experience of the National Center of Haematology. Haematologica, 90(Suppl 12): ELT07, 2005

  1. Chen WL, Tsai WC, Chao TY, Sheu LF, Chou JM, Kao WY, Chen YC, Ho CL. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol. 2010 Jun;89(6):553-62. Epub 2009 Dec 11.

  2. Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, Waqar A. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):229-32.

  3. Mwakiginia Amos R. Kaposi’s sarcoma amd Malignant Lymphomas in Tanzania during the AIDS Epidemy. Thesis. Department of Oncology and Pathology, Karolinska Institutet, ISBN: 978-91-7409-322-3, Karolinska University Press, 2009, cited on page 27, ref#181-page 43







Guenova M. & Balatzenko G., CD133-2 (AC141) Expression Analysis in Acute Leukemia Phenotyping in Correlation to CD34 and P-Glycoprotein. Hematology,;13(3):137-41, 2008

  1. Elgendi HM, Mekawy MA, Abdel Wahab SE, Tawfik LM, Ismail EA, Adly AA. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome. J Pediatr Hematol Oncol. 2010 May;32(4):286-93.



Shivarov, V., V. Nikolova, G. Balatzenko, M. Guenova Microgranular relapse of typical hypergranular acute promyelocytic leukemia, Leukemia & Lymphoma, 47 (12):2661-2663, 2006

  1. Cisleanu Diana, Ana-Maria Vladareanu, Mihaela Dervesteanu, Minodora Onisai; Horia Bumbea, Sinziana Radesi, Cristina Ciufu, Anca Nicolescu, Irina Voican, Anca Ilea, Acute promyelocytic leukemia microgranular variant – A clinical and therapeutical approach. Maedica/ A Journal of Clinical Medicine, Volume 2 No.4 2007 327-331

  2. Elgendi HM, Mekawy MA, Abdel Wahab SE, Tawfik LM, Ismail EA, Adly AA. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome. J Pediatr Hematol Oncol. 2010 May;32(4):286-93.




Лазаров, Р., Бакарджиев, С., Генова, М., Майнхард, П., Аврамова, Д., Кулаксъзов, П., Втори малигнени заболявания след лечение на болестта на Ходжкин. Пети национален конгрес по клинична и трансфузионна хематология с международно участие (Резюмета), София, 29-30 Октомври, 1993: 17

  1. Грудева, Ж., Балтов, И., Кирова, В., Спасов, Е., Кърнолски, И., Горанов, С., Пенчева, К., Вакрилов, В., Втори малигнен процес при болни с хронична миелогенна левкемия, Клинична и трансфузионна хематология, 32(1):24-27, 1996

  2. Кърнолски,.И., Малигнени хемопатии с последващо второ малигнено заболяване. Клинична и трансфузионна хематология, 32(1):11-15, 1996




Лазаров, Р., Бакарджиев, С., Генова, М., Майнхард, П., Аврамова, Д., Кулаксъзов, П., Втори малигнени заболявания след лечение на болестта на Ходжкин. Пети национален конгрес по клинична и трансфузионна хематология с международно участие (Резюмета), София, 29-30 Октомври, 1993: 17

  1. Грудева, Ж., Балтов, И., Кирова, В., Спасов, Е., Кърнолски, И., Горанов, С., Пенчева, К., Вакрилов, В., Втори малигнен процес при болни с хронична миелогенна левкемия, Клинична и трансфузионна хематология, 32(1):24-27, 1996

  2. Кърнолски,.И., Малигнени хемопатии с последващо второ малигнено заболяване. Клинична и трансфузионна хематология, 32(1):11-15, 1996




Генова, М., Втори малигнени заболявания при хематологично болни. Пета национална конференция “Съвременни проблеми на клиничната и трансфузионна хематология” с международно участие (Програма и сборник документи), София, 18-19 Октомври, 1991: 54

  1. Кърнолски,.И., Малигнени хемопатии с последващо второ малигнено заболяване. Клинична и трансфузионна хематология, 32(1):11-15, 1996




Генова, М., Мешков, Т., Майнхард, П., Хараламбиева, Е., Бойкова, К., Цитопатологично и хистологично изследване на костния мозък при миелодиспластичните синдроми. V Национален конгрес по патология с международно участие (Резюмета), София, 30 Септември – 2 Октомври, 1994: 4

  1. Кюркчиев, Г., Костномозъчната биопсия – същност, роля и значение в хемато- и онкопатологията. Дисертационен труд за придобиване на степен “Доктор на медицинските науки”, 1999




Майнхард, П., Хараламбиева, Е., Генова, М., Диагностични възможности на костномозъчната биопсия. V Национален конгрес по патология с международно участие (Резюмета), София, 30 Септември – 2 Октомври, 1994: 7

  1. Кюркчиев, Г., Костномозъчната биопсия – същност, роля и значение в хемато- и онкопатологията. Дисертационен труд за придобиване на степен “Доктор на медицинските науки”, 1999




Хараламбиева, Е., Генова, М., Майнхард, П., Хрисчев, В., Бойкова, К., Ангажиране на костния мозък от неходжкинови лимфоми. V Национален конгрес по патология с международно участие (Резюмета), София, 30 Септември - 2Октомври, 1994: 18

  1. Кюркчиев, Г., Костномозъчната биопсия – същност, роля и значение в хемато- и онкопатологията. Дисертационен труд за придобиване на степен “Доктор на медицинските науки”, 1999




Генова, М., Сарис, А., Прогностични модели при болестта на Ходжкин. Клинична и трансфузионна хематология, 35 (3-4): 43-49, 1999

  1. Лазаров, Р., Бакърджиев, Ст., Кирова, Г., Лъчелечение при болни с болест на Ходжкин с голяма медиастинална формация и/или едностранна инфилтрация на белия дроб. Рентгенология и радиология, 39 (4), 2000




Balatzenko G., Ganeva P., Guenova M., Toshkov S. Abstract book, Joint International Congress on APL and differentiation therapy. 2001, стр.32, P2.13

  1. Савченко ВГ, Паровичникова ЕН, Острьiй промиелоцитарньiй лейкоз. Москва Издательство „Литтерра”, 2010, стр. 13. реф. № 36




_________________________________________________

Цитирания

Стр. от

Свързани:

Списък на цитиранията на публикации на iconМониторинг Cor Caroli Bavaria Yachts 2012
В 9 национални всекидневника: в. 24 часа в. Всеки ден 2 публикации в. Дума в. Класа в. Монитор 3 публикации в. Преса -3 публикации...
Списък на цитиранията на публикации на iconСписък на цитиранията на капитан I ранг професор д в. н. Боян Кирилов Медникаров
Медникаров, Б., С. Стойков, К. Калинов. Система за защита на пристанища и военноморски бази. // Военен журнал, 2009, №1
Списък на цитиранията на публикации на iconСписък на научните публикации
Научни публикации по дисертационния труд за придобиване на научна степен „доктор” по научна специалност 02. 18. 02 Механизация и...
Списък на цитиранията на публикации на icon2 2) Списък на публикации (български)

Списък на цитиранията на публикации на iconВниманию авторов! Здесь мы сообщаем о тезисах поступивших на публикацию, а не о принятых к публикации. Пометка отказ рядом с тезисами, не принятыми к публикации
Об отказе в публикации авторам будет сообщено по электронным адресам, указанным в регистрационных картах, после окончания приема...
Списък на цитиранията на публикации на iconЧавдар Георгиев Лозанов Списък на научните публикации I. Articles

Списък на цитиранията на публикации на iconСписък с публикации* от и за приснопаметния Български патриарх академик д-р Кирил

Списък на цитиранията на публикации на iconСписък на материалите, които участниците в конкурс за заемане на
Списък и екземпляри от научноизследователски трудове, публикации, научно и научно-приложни разработки, които не повтарят представените...
Списък на цитиранията на публикации на iconMИндекс на цитиранията на „Приказка за претърпелия корабокрушение, пап. Ермитраж 1115 в граматиката на сър Алън Гардинър
Индекс на цитиранията на „Приказка за претърпелия корабокрушение”, пап. Ермитраж 1115 в граматиката на сър Алън Гардинър
Списък на цитиранията на публикации на iconИндекс на цитиранията на пап. Весткар (pap. Berlin 3033) в граматиката на сър Алан Гардинър (Oxford, 3
Индекс на цитиранията на пап. Весткар (pap. Berlin 3033) в граматиката на сър Алан Гардинър (Oxford, 3rd ed., 1957)
Поставете бутон на вашия сайт:
Документация


Базата данни е защитена от авторски права ©bgconv.com 2012
прилага по отношение на администрацията
Документация
Дом